These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3511688)

  • 1. Carcinoembryonic antigen in breast cancer. Clinical review.
    Beard DB; Haskell CM
    Am J Med; 1986 Feb; 80(2):241-5. PubMed ID: 3511688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoembryonic antigen in bone metastases. Diagnostic and prognostic value].
    Colson F; Gioud M; Bonvoisin B; Lejeune E; Bouvier M
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):621-5. PubMed ID: 6523014
    [No Abstract]   [Full Text] [Related]  

  • 4. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasis.
    Chatal JF; Chupin F; Ricolleau G; Tellier JL; le Mevel A; Fumoleau P; Godin O; le Mevel BP
    Eur J Cancer (1965); 1981 Feb; 17(2):233-8. PubMed ID: 7262160
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique.
    Walker RA
    J Clin Pathol; 1980 Apr; 33(4):356-60. PubMed ID: 6995487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
    Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
    Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen.
    Fletcher RH
    Ann Intern Med; 1986 Jan; 104(1):66-73. PubMed ID: 3510056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carcinoembryonic antigen in human mammary carcinoma.
    Chu TM; Nemoto T
    J Natl Cancer Inst; 1973 Oct; 51(4):1119-22. PubMed ID: 4745852
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen in patients with breast or colon cancer.
    Lee YN
    West J Med; 1978 Nov; 129(5):374-80. PubMed ID: 364839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma.
    Silver HK; Archibald BL; Ragaz J; Coldman AJ
    Cancer Res; 1991 Apr; 51(7):1904-9. PubMed ID: 2004374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostaining for carcinoembryonic antigen does not discriminate for early recurrence in breast cancer. The ECOG experience.
    Gilchrist KW; Kalish L; Gould VE; Hirschl S; Imbriglia JE; Levy WM; Patchefsky AS; Pickren J; Roth JA; Schinella RA
    Cancer; 1985 Jul; 56(2):351-5. PubMed ID: 3891068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for carcinoembryonic antigen: its application to diagnosis and post-treatment follow up of human cancer. A review.
    Khoo SK
    Med J Aust; 1974 Jun; 1(26):1025-9. PubMed ID: 4605005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
    Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
    Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
    Molina R; Jo J; Zanón G; Filella X; Farrus B; Muñoz M; Latre ML; Pahisa J; Velasco M; Fernandez P; Estapé J; Ballesta AM
    Br J Cancer; 1996 Oct; 74(7):1126-31. PubMed ID: 8855986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
    Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
    Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer.
    Wang DY; Bulbrook RA; Hayward JL; Hendrick JC; Franchimont P
    Eur J Cancer (1965); 1975 Sep; 11(9):615-8. PubMed ID: 1220977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carcinoembryonic antigen (CEA) in breast cancer].
    Góźdź S; Słuszniak J; Bukowski J; Kowalski D; Zagała A; Urbania A; Gorazda-Postuła L; Korejba W; Banasińska E
    Nowotwory; 1985; 35(4):305-9. PubMed ID: 3831945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.